DalsnaFinance › IPOs › CytomX Therapeutics › IPO
CytomX Therapeutics, Inc. completed its initial public offering on NASDAQ on October 8, 2015, pricing at $12.00 a share.
| Ticker | CTMX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 8, 2015 |
| Offering price | $12.00 |
| Shares offered | 6,666,667 |
| Total raised | $80M |
CytomX Therapeutics, Inc. sold 6,666,667 shares at $12.00 each on NASDAQ. Multiplied out, that is $80 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $80 million total recorded for the deal.
CytomX Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for CytomX Therapeutics, Inc.. This page is general information, not investment advice.